Bio-Pharma Developments: Bass, Biologics, and Small Molecules

The use of IPR challenges in the bio-pharma space continues to grow. Fish speakers Dorothy Whelan and Tasha Francis  discussed the latest noteworthy developments. Topics included the Bass hedge fund filings and the PTAB’s decision not to prohibit such filings as an abuse of process. Additional topics reviewed were: recent institutions and final written decisions, including presenting pointers for both petitioners and patent owners.